Picture loading failed.

Anti-TYRP1 therapeutic antibody (Pre-made Flanvotumab biosimilar,Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Flanvotumab, also known as IMC-20D7S, is a human monoclonal antibody designed for the treatment of melanoma. It targets TYRP1.

Order informatioin

Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-216-1mg 1mg 3090
GMP-Bios-ab-216-10mg 10mg 21890
GMP-Bios-ab-216-100mg 100mg 148000
GMP-Bios-ab-216-xmg ≥100mg Inquiry
Shipping Cost: 760.00


Products Name (INN Index) Anti-TYRP1 therapeutic antibody (Pre-made Flanvotumab biosimilar,Whole mAb)
INN Name Flanvotumab
FormatWhole mAb
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-I
Est. StatusDiscontinued
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2011
Year Recommended2012
CompaniesImClone Systems;Eli Lilly
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedMalignant melanoma
Development Techna